The Effect of Empagliflozin and Liraglutide on the NLRP3 Inflammasome in a rodent model of type 2 Diabetes Mellitus
Publication date: Available online 21 November 2020Source: Canadian Journal of DiabetesAuthor(s): Mark Gordon, Patrick Meagher, Kim A. Connelly
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Canada Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Jardiance | Victoza